Some findings also revealed that Vildagliptin reduced glucagon during hyperglycemia and maintained its counterregulation during hypoglycemia in T1DM16,17, resulting in reduction in fasting plasma glucose, postprandial plasma glucose, and prevention of hypoglycemia. Here, GCG is linked to Hypoglycemia.